Convolutional Neural Networks for Classification of Alzheimer's Disease: Overview and Reproducible Evaluation

Junhao Wen (1, 2) , Elina Thibeau-Sutre (1, 2) , Mauricio Diaz-Melo (1, 2) , Jorge Samper-González (1, 2) , Alexandre Routier (1, 2) , Simona Bottani (1, 2) , Didier Dormont (3, 2) , Stanley Durrleman (1, 2) , Ninon Burgos (1, 2) , Olivier Colliot (1, 2)

1 ARAMIS - Algorithms, models and methods for images and signals of the human brain = Algorithmes, modèles et méthodes pour les images et les signaux du cerveau humain [ICM Paris]
2 SU - Sorbonne Université
3 ICM - Institut du Cerveau = Paris Brain Institute

Numerous machine learning (ML) approaches have been proposed for automatic classification of Alzheimer's disease (AD) from brain imaging data. In particular, over 30 papers have proposed to use convolutional neural networks (CNN) for AD classification from anatomical MRI. However, the classification performance is difficult to compare across studies due to variations in components such as participant selection, image preprocessing or validation procedure. Moreover, these studies are hardly reproducible because their frameworks are not publicly accessible and because implementation details are lacking. Lastly, some of these papers may report a biased performance due to inadequate or unclear validation or model selection procedures. In the present work, we aim to address these limitations through three main contributions. First, we performed a systematic literature review. We identified four main types of approaches: i) 2D slice-level, ii) 3D patch-level, iii) ROI-based and iv) 3D subject-level CNN. Moreover, we found that more than half of the surveyed papers may have suffered from data leakage and thus reported biased performance. Our second contribution is the extension of our open-source framework for classification of AD using CNN and T1-weighted MRI. The framework comprises previously developed tools to automatically convert ADNI, AIBL and OASIS data into the BIDS standard, and a modular set of image preprocessing procedures, classification architectures and evaluation procedures dedicated to deep learning. Finally, we used this framework to rigorously compare different CNN architectures. The data was split into training/validation/test sets at the very beginning and only the training/validation sets were used for model selection. To avoid any overfitting, the test sets were left untouched until the end of the peer-review process. Overall, the different 3D approaches (3D-subject, 3D-ROI, 3D-patch) achieved similar performances while that of the 2D slice approach was lower. Of note, the different CNN approaches did not perform better than a SVM with voxel-based features. The different approaches generalized well to similar populations but not to datasets with different inclusion criteria or demographical characteristics. All the code of the framework and the experiments is publicly available: general-purpose tools have been integrated into the Clinica software (www.clinica.run) and the paper-specific code is available at: https://github.com/aramis-lab/AD-DL.

Mots clés: Reproducibility; Alzheimer's disease classification; Convolutional neural network; Magnetic resonance imaging

Domaines: Imagerie médicale; Intelligence artificielle [cs.AI]; Bio-informatique [q-bio.QM]

Junhao Wen, Elina Thibeau-Sutre, Mauricio Diaz-Melo, Jorge Samper-González, Alexandre Routier, et al.. Convolutional Neural Networks for Classification of Alzheimer's Disease: Overview and Reproducible Evaluation. Medical Image Analysis, 2020, 63, pp.101694. ⟨10.1016/j.media.2020.101694⟩. ⟨hal-02562504v2⟩